Priorities for the National Vaccine Plan

Priorities for the National Vaccine Plan
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 368
Release: 2010-05-17
Genre: Medical
ISBN: 0309156203

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.

Wildlife in a Changing World

Wildlife in a Changing World
Author: Jean-Christophe ViƩ
Publisher: IUCN
Total Pages: 184
Release: 2009
Genre: Biodiversity conservation
ISBN: 2831710634

"Wildlife in a Changing World" presents an analysis of the 2008 IUCN Red List of Threatened Species. Beginning with an explanation of the IUCN Red List as a key conservation tool, it goes on to discuss the state of the world s species and provides the latest information on the patterns of species facing extinction in some of the most important ecosystems in the world, highlighting the reasons behind their declining status. Areas of focus in the report include: freshwater biodiversity, the status of the world s marine species, species susceptibility to climate change impacts, the Mediterranean biodiversity hot spot, and broadening the coverage of biodiversity assessments."

Market Definition in EU Competition Law

Market Definition in EU Competition Law
Author: Miguel Sousa Ferro
Publisher: Edward Elgar Publishing
Total Pages: 522
Release: 2019
Genre: Antitrust law
ISBN: 1788118391

The maintenance of a fair, competitive market among member states is critical to the functioning of the EU economy. In this book, the first comprehensive, unifying view of market definition, Miguel Ferro adeptly explores the different economic-legal issues that arise in EU competition law.

Immunization Safety Review

Immunization Safety Review
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 214
Release: 2004-09-30
Genre: Medical
ISBN: 030909237X

This eighth and final report of the Immunization Safety Review Committee examines the hypothesis that vaccines, specifically the measles-mumps-rubella (MMR) vaccine and thimerosal-containing vaccines, are causally associated with autism. The committee reviewed the extant published and unpublished epidemiological studies regarding causality and studies of potential biologic mechanisms by which these immunizations might cause autism. Immunization Safety Review: Vaccines and Autism finds that the body of epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism. The book further finds that potential biological mechanisms for vaccine-induced autism that have been generated to date are only theoretical. It recommends a public health response that fully supports an array of vaccine safety activities and recommends that available funding for autism research be channeled to the most promising areas. The book makes additional recommendations regarding surveillance and epidemiological research, clinical studies, and communication related to these vaccine safety concerns.

Vaccine Safety Research, Data Access, and Public Trust

Vaccine Safety Research, Data Access, and Public Trust
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 152
Release: 2005-04-29
Genre: Medical
ISBN: 0309165245

The Vaccine Safety Datalink (VSD) is a large, linked database of patient information that was developed jointly by CDC and several private managed care organizations in 1991. It includes data on vaccination histories, health outcomes, and characteristics of more than 7 million patients of eight participating health organizations. Researchers from CDC and the managed care groups have used VSD information to study whether health problems are associated with vaccinations. The subsequent VSD data sharing program was launched in 2002 to allow independent, external researchers access to information in the database. In this report, the committee that was asked to review aspects of this program recommends that two new oversight groups are needed to ensure that the policies and procedures of the VSD and its data sharing program are implemented as fairly and openly as possible.

Early Drug Development, 2 Volume Set

Early Drug Development, 2 Volume Set
Author: Fabrizio Giordanetto
Publisher: John Wiley & Sons
Total Pages: 810
Release: 2018-12-10
Genre: Science
ISBN: 3527341498

This one-stop reference systematically covers key aspects in early drug development that are directly relevant to the discovery phase and are required for first-in-human studies. Its broad scope brings together critical knowledge from many disciplines, ranging from process technology to pharmacology to intellectual property issues. After introducing the overall early development workflow, the critical steps of early drug development are described in a sequential and enabling order: the availability of the drug substance and that of the drug product, the prediction of pharmacokinetics and -dynamics, as well as that of drug safety. The final section focuses on intellectual property aspects during early clinical development. The emphasis throughout is on recent case studies to exemplify salient points, resulting in an abundance of practice-oriented information that is usually not available from other sources. Aimed at medicinal chemists in industry as well as academia, this invaluable reference enables readers to understand and navigate the challenges in developing clinical candidate molecules that can be successfully used in phase one clinical trials.